RPX’s CEO released a statement on our response to the COVID-19 emergency. Click here to access.

RPX’s CEO released a statement on our response to the COVID-19 emergency. Click here to access.

Analyte monitoring system and methods of use

  • US 10,082,493 B2
  • Filed: 04/29/2016
  • Issued: 09/25/2018
  • Est. Priority Date: 11/25/2011
  • Status: Active Grant
  • ×

    Create Patent Alert


    *Certain alert events are not available for your current subscription level. Upgrade
  • Save